Press Release
Japan Airlines again named "Best Trans-Pacific Airline" and "Best Airline to Japan" in Global Traveler - GT Tested Reader survey
Japan Airlines (JAL), a member of the oneworld® alliance of leading airlines, has been named “Best Trans-Pacific Airline” and “Best Airline to Japan” for the second consecutive year by readers of Global Traveler, the monthly magazine written exclusively for frequent, luxury-business and leisure travelers.
For the publication’s 15th Annual GT Tested Reader Survey Awards, Global Traveler conducted its 2018 GT Tested Reader Survey during January to September 2018, asking travelers to name their choice for best in a variety of travel-related categories. More than 20,000 subscribers responded to the survey.
“Japan Airlines is pleased to receive these two awards from the readers of Global Traveler for the second consecutive year,” said Hideki Takarada, JAL’s Vice President, Passenger Marketing, the Americas. “This demonstrates that we are realizing our mission to ensure our customers receive a superior travel experience each and every time they board a Japan Airlines flight.”
Hideki Takarada, Japan Airlines’ Vice President Passenger Marketing - The Americas (left)
at The Peninsula Beverly Hills. The award was presented by author and humanitarian Terry Waite.
As part of its Medium Term Management Plan, JAL has been investing in its products and services to provide an improved customer experience through all points of travel. The highly acclaimed `JAL SKY SUITE` aircraft offers the airline’s latest in-flight products, and the airline recently announced that JAL SKY SUITE aircraft will be introduced onto the Los Angeles—Osaka (Kansai) route from March 31, 2019.
Japan Airlines operates over 100 flights per week to/from the U.S. and Canada, which include Boston, New York, Chicago, Dallas/Fort Worth, Los Angeles, San Francisco, San Diego, Honolulu, Kona, Guam and Vancouver. The airline is scheduled to launch new daily Seattle-to-Tokyo service starting March 31, 2019 subject to government approval.
###